Skip to main content
Top

Hematology and Cell Therapy

Issue 4/1999

Content (9 Articles)

Review articles

Infectious complications in chronic lymphocytic leukaemia

E. Morra, A. Nosari, M. Montillo

Original articles

Contributions of p53 and PMA to g-irradiation induced apoptosis in Jurkat cells

E. Vigorito, S. Plaza, L. Mir, L. Mongay, O. Viñas, C. Serra-Pagès, J. Vives

Original articles

Megakaryocytopoiesis in refractory chronic immune thrombocytopenia

N. Suvajdzic, Z. Rolovic, I. Elezovic, M. Colovic

Original articles

Molecular basis to understand polyploidy

S. Baatout

Original articles

Evaluation of hematopoietic progenitors in hematopoietic progenitor cell transplants. CD34+ dose effect in marrow recovery. Retrospective analysis in 38 patients

R. Gabús, A. Magariños, M. Zamora, E. De Lisa, A.I. Landoni, G. Martínez, C. Canessa, H. Giordano, E. Bodega

Original article

Myelodysplastic syndrome (MDS) associated with increased hemoglobin F and trisomy 8: presentation of a patient

A. Koç, R. öner, C. öner, D. Aktas, M. Sözen, E. Tunçbilek, C. Altay

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine